Building patient-focused companies around transformative technologies.

Hibiscus BioVentures provides the Technology, Capital and People necessary to build transformative biotechnology companies.

Our Mission

Committed to significantly moving patient care forward by supporting development of commercially viable therapeutics and diagnostics. Providing all the resources necessary in-house to identify major unmet medical needs and drive impactful solutions for patients.

 

Hibiscus Biotechnology Logo

Venture studio focused on building companies from the ground up around innovative technologies.

Hibiscus Capital Management Logo

Patient-focused venture capital arm investing in transformative biotechnology companies.

Our Latest News

Innoforce Pharma Featured Image

Innoforce and Hibiscus BioVentures Announce Strategic Partnership to Enable Development of Advanced Therapies

| All | No Comments
- Partnership enables Hibiscus BioTechnology Studio Companies access to Innoforce's advanced therapies drug development capabilities - HANGZHOU, China and ROCKVILLE, Md., March 16, 2022 /PRNewswire/ -- Innoforce, a global development…
Peripheral Artery Disease (PAD) Post image

Regio Biosciences Enters into License Agreement with AstraZeneca for Phase 2a Asset in Peripheral Artery Disease (PAD)

| All | No Comments
February 03, 2022 07:05 AM Eastern Standard Time ROCKVILLE, Md.--(BUSINESS WIRE)--Regio Biosciences (Regio),a Hibiscus BioVentures company, announced today it has entered into an exclusive license agreement with AstraZeneca to further…
Karmanos Logo

Hibiscus BioVentures Partners with the Barbara Ann Karmanos Cancer Institute to Advance Translational Cancer Research

| All | No Comments
- Partnership aims to drive innovation and clinical development of novel therapeutics for cancer treatment - ROCKVILLE, Md.--(BUSINESS WIRE)--Hibiscus BioVentures, a firm committed to building patient-focused companies around transformative technologies,…